Has Ying Lin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $241 in general payments to Ying Lin, MD across 8 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ying Lin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ying Lin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ying Lin, MD

Internal Medicine · Sea Girt, NJNPI 1689647240

Payments from drug & device makers

$241in general payments, 2019–2025

Across 8 payments — averaging $30.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Fresenius USA Marketing, Inc.$121
GSK$65
Nevro Corp.$21
Boehringer Ingelheim$17
AstraZeneca$16

What the payments were for

Food & beverage$241100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Fresenius USA Marketing, Inc.	1	$121
GSK	4	$65
Nevro Corp.	1	$21
Boehringer Ingelheim	1	$17
AstraZeneca	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Velphoro$121

How this compares

$241 in reported general payments places this provider in the 40th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Medicare billing

Part B allowed, 2024

$259,313

Medicare patients

556

Services billed

3,667

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JanuviaSitagliptin Phosphate	67	$64,991
EliquisApixaban	27	$24,464
OzempicSemaglutide	15	$18,673
SynthroidLevothyroxine Sodium	114	$7,677
Valsartan	180	$6,230
Levothyroxine Sodium	502	$6,159
Atorvastatin Calcium	462	$4,336
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide	83	$3,712
Rosuvastatin Calcium	320	$3,281
Metoprolol Succinate	194	$3,025
Ezetimibe	83	$2,860
PaxlovidNirmatrelvir/Ritonavir	20	$2,859
Amlodipine Besylate	433	$2,607
Simvastatin	199	$2,226
Losartan Potassium	178	$1,949

Paid to pharmacies, not to this prescriber.

Other internal medicine in Sea Girt

Sanjiv SharmaToms River$33.9M
Jeffrey CarsonNew Brunswick$13.8M
Samer HaddadHamilton$6.8M
Magdy ShenoudaWall$3.7M
Samar HameedLivingston$3.6M
Jane RohlfTrenton$2.7M
Mohammed NisarEdison$2.6M
Michael CasserNew Milford$2.2M
Sumitha ReddyHamilton$2M
Helio PedroNewark$1.8M

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →